Rheumatoid Arthritis Current Events | Rheumatoid Arthritis News | 7
|
| Page
7 of
22 |
438 Results |
|
|
|
Sort By:
Page Views | Date |
Infliximab Could Prevent Sight Loss From Behcet's Disease (p 295)
A drug used to treat rheumatoid arthritis and Crohn's disease could play an important role in preventing sight loss associated with the inflammatory disorder Behcet's disease, suggest authors of a fast-track research letter published in this week's issue of THE LANCET. Beh'§et's disease is a rare condition (although with increased incidence in... view more... (2001-07-25)
Researchers map of genetic variations implicated in disease
Sequence differences in less than 0.2% of the 3-billion-base human genome play a vital role in a bewildering variety of human disease. view more (2006-01-27)
New Rheumatoid Arthritis Drug Developed at UCSD Promises Improved Treatment Option
Researchers at the University of California, San Diego (UCSD) School of Medicine have announced successful completion of Phase II clinical trials of a novel drug for the treatment of rheumatoid arthritis (RA), one that works without suppressing the patient's immune system. view more (2005-10-17)
INFLIXIMAB COULD OFFER LONG-TERM BENEFITS TO PEOPLE WITH CROHN'S DISEASE (p 1541)
Sustained use of the drug infliximab could offer substantial clinical benefit to people with Crohn's disease, conclude authors of a study in this week's issue of THE LANCET. Crohn's disease is a chronic inflammatory disorder of the intestines. Patients often have to be treated with steroids, which are associated with severe side-effects. Previous... view more... (2002-05-01)
Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events
Certain cardiovascular disease (CVD) risk factors and rheumatoid arthritis (RA) disease factors have a similar effect on an RA patient's risk of experiencing myocardial infarction (MI) or stroke. view more (2008-06-16)
U-M study offers new perspective on nitric oxide signaling in rheumatoid arthritis
Scientists at the University of Michigan Medical School have found evidence that challenges current thinking about the cause of rheumatoid arthritis (RA), a chronic inflammatory disease that damages joints, causes pain, loss of movement, and bone deformities in 2.1 million Americans. view more (2006-10-31)
Study Identifies Genetic Risk Factor for Rheumatoid Arthritis, Lupus
A genetic variation has been identified that increases the risk of two chronic, autoimmune inflammatory diseases: rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus). view more (2007-09-07)
Arthritis self-management does not reduce pain levels or GP visits
Self-management programmes for people with osteoarthritis do not reduce pain, or the number of visits patients make to their GP, a new study reveals today. view more (2006-10-16)
New treatment strategy offers hope to RA patients who failed all other therapies
Rheumatoid arthritis (RA) patients who failed to respond to initial treatment with rituximab (RTX) (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second course of RTX after six months. view more (2009-06-12)
Popular cancer drug linked to often fatal brain virus
The 57-year-old lawyer in New York had handily completed the New York Times' Saturday crossword puzzle - the hardest of the week - for years. But one Saturday morning, suddenly he couldn't retrieve the words to fill in the squares. view more (2009-05-19)
Pain thresholds linked to inflammation and sleep problems in arthritis patients
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain. view more (2009-10-29)
Gene expression findings a step toward better classification and treatment of juvenile arthritis
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). view more (2009-06-30)
First multinational study of Tocilizumab reports in
Nearly half (43.9%) of rheumatoid arthritis (RA) patients receiving tocilizumab 8mg/kg, in addition to ongoing methotrexate therapy experienced a 50% (ACR50) improvement in symptoms at 24 weeks and more than one fifth achieved a 70% symptom improvement. view more (2007-06-18)
New report: Arthritis is a potential barrier to physical activity for adults with diabetes
People with diagnosed diabetes are nearly twice as likely to have arthritis, and the inactivity caused by arthritis hinders the successful management of both diseases, according to a new Morbidity and Mortality Weekly Report (MMWR) study released today by the Centers for Disease Control and Prevention (CDC). view more (2008-05-09)
Counseling, coping skills could reduce arthritis disability
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life, according to a new systematic review. view more (2007-05-11)
Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis
Undertaking a supervised exercise programme can have beneficial effects on functional status and physical function, reduce the need for daily corticosteroid and anti-inflammatory intake and improve levels of depression and anxiety in people with rheumatoid arthritis (RA). view more (2009-06-11)
Arthritis drug might prove effective in fighting the flu, study suggests
Researchers at the University of Maryland School of Medicine have found that an approved drug for treating rheumatoid arthritis reduces severe illness and death in mice exposed to the Influenza A virus. view more (2009-05-27)
Arthritis Hinders Vital Physical Activity for Adults with Heart Disease
Arthritis affects more than half of adults with heart disease and appears to be a substantial barrier to utilizing physical activity to help manage their condition, according to a new Morbidity and Mortality Weekly Report (MMWR) study released today by the Centers for Disease Control and Prevention (CDC). view more (2009-02-27)
Study helps explain how allergic reactions are triggered
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the... view more... (2008-01-15)
Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases
In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune... view more... (2007-04-11)
|
|
| Page
7 of
22 |
438 Results |
|
|
|
Sort By:
Page Views | Date |
|
